Prosecution Insights
Prosecution Insights
45 pending office actions • 32 art units • 43 examiners • 0 of 45 (0%) have an AI response strategy ready • 47 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (13%) |
| §103 only | 13 (29%) |
| §102 only | 3 (7%) |
| §112 only | 3 (7%) |
| Double-patenting + other | 3 (7%) |
| Multi-statute (no §101) | 17 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLEVINS, JERRY M | 2 | 87.5% | +4.9% |
| HINES, JANA A | 2 | 53.0% | +39.6% |
| SITTA, GRANT | 1 | 72.2% | +13.7% |
| HADDAD, MAHER M | 1 | 50.5% | +53.9% |
| RACHEDINE, MOHAMMED | 1 | 86.9% | +11.4% |
| EINHORN, MICA JILLIAN | 1 | 100.0% | +0.0% |
| MILO, MICHAEL | 1 | 50.0% | +54.9% |
| JACKSON-TONGUE, LAKIA J | 1 | 68.8% | +20.8% |
| CHUNDURU, SURYAPRABHA | 1 | 53.4% | +17.5% |
| PADDA, ARI SINGH KANE | 1 | 24.1% | +13.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852333 | OPTICAL CAVITY WITH ONE OR MORE INTRACAVITY LENSES, AND ASSOCIATED METHODS | EINHORN, MICA JILLIAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765176 | LAMELLAR IRON SULFIDES WITH EMBEDDED CATIONS FOR ELECTRICAL ENERGY STORAGE | NGUYEN, KEVIN NMN | 73d overdue |
| 17987649 | Mechanism and Methods for Quantifying the Tactile Acuity of the Human Breast | MCCORMACK, ERIN KATHLEEN | 19d overdue |
| 18019972 | Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses | RAO, SAVITHA M | 18d overdue |
| 17597793 | COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS | PETERS, ALEC JON | 16d |
| 18578190 | MULTI-FUNCTION CATHETER AND METHODS FOR DIAGNOSIS AND/OR TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE | NGUYEN, ANDREW H | 49d |
| 18291887 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | PADDA, ARI SINGH KANE | 83d |
| 18971607 | LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS | HADDAD, MAHER M | — |
| 18900073 | INDIVIDUALIZED GENERATIVE MODELS FOR IMAGE GENERATION AND MANIPULATION | RACHEDINE, MOHAMMED | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | HINES, JANA A | 119d overdue |
| 19060948 | Lip-based user interface system | SITTA, GRANT | 56d overdue |
| 18847129 | TRANSRADIAL APPROACH/ANGIOGRAPHY BOARD | MILO, MICHAEL | 17d overdue |
| 18291887 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | PADDA, ARI SINGH KANE | 83d |
| 18971607 | LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS | HADDAD, MAHER M | — |
| 18900073 | INDIVIDUALIZED GENERATIVE MODELS FOR IMAGE GENERATION AND MANIPULATION | RACHEDINE, MOHAMMED | — |
| 18708530 | METHODS AND COMPOSITIONS FOR PKC-DELTA INHIBITION AND CANCER IMMUNOTHERAPY | JACKSON-TONGUE, LAKIA J | — |
| 18694220 | UNIVERSAL HAIRPIN PRIMER SYSTEM FOR QUANTIFICATION OF MICRORNA | CHUNDURU, SURYAPRABHA | — |
| Art Unit | Apps |
|---|---|
| 1645 | 3 |
| 1641 | 3 |
| 3791 | 2 |
| 1651 | 2 |
| 1643 | 2 |
| 2622 | 1 |
| 3786 | 1 |
| 2897 | 1 |
| 3741 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19060948 | Lip-based user interface system | SITTA, GRANT | 2622 | §103 | Final Rejection | 56d overdue | Pending | Feb 24, 2025 |
| 18971607 | LOW-DOSE TOCILIZUMAB FOR THE TREATMENT OR PREVENTION OF SICKLE CELL CRISIS | HADDAD, MAHER M | — | §103§112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18900073 | INDIVIDUALIZED GENERATIVE MODELS FOR IMAGE GENERATION AND MANIPULATION | RACHEDINE, MOHAMMED | — | §101§103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18852333 | OPTICAL CAVITY WITH ONE OR MORE INTRACAVITY LENSES, AND ASSOCIATED METHODS | EINHORN, MICA JILLIAN | — | §103 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18847129 | TRANSRADIAL APPROACH/ANGIOGRAPHY BOARD | MILO, MICHAEL | 3786 | §103 | Final Rejection | 17d overdue | Pending | Sep 13, 2024 |
| 18799797 | WAFER-SCALE WAVEGUIDES FOR INTEGRATED TWO-DIMENSIONAL PHOTONICS | BLEVINS, JERRY M | — | §101§102§103 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18798493 | WAFER-SCALE WAVEGUIDES FOR INTEGRATED TWO-DIMENSIONAL PHOTONICS | BLEVINS, JERRY M | — | §101§102§103 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18708530 | METHODS AND COMPOSITIONS FOR PKC-DELTA INHIBITION AND CANCER IMMUNOTHERAPY | JACKSON-TONGUE, LAKIA J | 1645 | §102§112 | Non-Final OA | — | Pending | May 08, 2024 |
| 18694220 | UNIVERSAL HAIRPIN PRIMER SYSTEM FOR QUANTIFICATION OF MICRORNA | CHUNDURU, SURYAPRABHA | — | §102 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18425731 | PROBIOTICS TO RESCUE MATERNAL IMMUNE ACTIVATION-INDUCED NEURODEVELOPMENT DEFICITS | HINES, JANA A | 1645 | §102 | Non-Final OA | 119d overdue | Pending | Jan 29, 2024 |
| 18291887 | CONTINUOUS MONITORING WITH NANO-DIAMOND HYDROGEL IN MICRONEEDLES | PADDA, ARI SINGH KANE | 3791 | §102§103§112 | Non-Final OA | 83d | Pending | Jan 24, 2024 |
| 18416403 | SEMICONDUCTOR DEVICE INCLUDING TWO-DIMENSIONAL MATERIAL AND METHOD OF MANUFACTURING THE SAME | MANN, WILLIAM ROBERT | 2897 | §103§112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18578190 | MULTI-FUNCTION CATHETER AND METHODS FOR DIAGNOSIS AND/OR TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE | NGUYEN, ANDREW H | 3741 | §103§112 | Non-Final OA | 49d | Pending | Jan 10, 2024 |
| 18558527 | METHODS AND COMPOSITIONS FOR TARGETING OF ANTIGENS AND OTHER POLYPEPTIDES TO FIRST RESPONDER DENDRITIC CELLS | CESARE, JOSEPH DAVID | 1641 | §102§103§112 | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18556006 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS WITH ORAL SYSTEMICALLY BIOAVAILABLE BUTYRATE CONJUGATES | NEAGU, IRINA | 1629 | §103§112 | Non-Final OA | — | Pending | Oct 18, 2023 |
| 18448454 | METHODS FOR DETERMINING RISK OF MORTALITY FROM COVID-19 | ARIANI, KADE | 1651 | §101§102§103 | Non-Final OA | — | Pending | Aug 11, 2023 |
| 18274444 | FUNCTIONALIZED NANOPARTICLES FOR THE CONTAINMENT AND CLEARANCE OF PATHOGENS | CHANDRA, GYAN | 1674 | §103§112 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18206235 | METHODS FOR FABRICATING GRAPHENE NANORIBBONS | HENDRICKSON, STUART L | 1736 | §112 | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18329289 | ALL-TRANS RETINOIC ACID ENHANCES RADIOTHERAPY AND OVERCOMES IMMUNE SUPPRESSION FOR CANCER THERAPY | SIMMONS, CHRIS E | 1622 | §102§103 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18254301 | POROUS AND MONOLITHIC CARBON MEMBRANES AND THEIR USE | HUANG, RYAN | 1777 | §103 | Final Rejection | 30d | Pending | May 24, 2023 |
| 18035678 | HAIRPIN OLIGONUCLEOTIDES AND USES THEREOF | BUNKER, AMY M | 1684 | §103§112 | Non-Final OA | — | Pending | May 05, 2023 |
| 18191495 | SLIDE-LEVEL UNCERTAINTY QUANTIFICATION FOR DEEP LEARNING PREDICTIONS IN DIGITAL HISTOPATHOLOGY | AUGER, NOAH ANDREW | 2122 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 28, 2023 |
| 18042958 | Nucleic Acid-Derivatized Therapeutics | VAN DRUFF, SYDNEY | 1643 | §103§112 | Final Rejection | — | Pending | Feb 24, 2023 |
| 18022004 | MODIFIED SERINE PROTEASE PROPROTEINS | ARMATO JR, DENNIS IGNATIUS | 1651 | §103 | Non-Final OA | 15d overdue | Pending | Feb 17, 2023 |
| 18019972 | Pharmaceuticals for Treating or Preventing Nidoviruses and Picornaviruses | RAO, SAVITHA M | 1691 | §102§112 | Final Rejection | 18d overdue | Pending | Feb 06, 2023 |
| 18006482 | Inhibitors of the Artemin Pathway for Treatment of Cancer | WEBB, WALTER E | 1612 | §103 | Final Rejection | 20d | Pending | Jan 23, 2023 |
| 18156254 | Classical Algorithm for Generating Multi-Mode Bosonic Transition Spectra by Phase Space Sampling | FUELLING, MICHAEL | 2199 | §103 | Non-Final OA | — | Pending | Jan 18, 2023 |
| 18067192 | Methods of Using Multi-Tissue Organoids | DAUNER, JOSEPH G | 1682 | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 17927168 | METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPY | WORSHAM, JESSICA N | 1615 | §102§103DP | Final Rejection | — | Pending | Nov 22, 2022 |
| 17987649 | Mechanism and Methods for Quantifying the Tactile Acuity of the Human Breast | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Non-Final OA | 19d overdue | Pending | Nov 15, 2022 |
| 18052449 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | PECKHAM, RICHARD GRANT | 1627 | §112 | Non-Final OA | — | Pending | Nov 03, 2022 |
| 17995225 | TOCILIZUMAB FOR THE TREATMENT OF VIRAL INFECTIONS | NICKOL, GARY B | 1643 | §102 | Non-Final OA | 146d overdue | Pending | Sep 30, 2022 |
| 17754797 | METHODS AND COMPOSITIONS COMPRISING MODIFIED FAB SCAFFOLDS AND PROTEIN G FAB BINDING DOMAINS | YU, MISOOK | 1641 | DPOther | Final Rejection | — | Pending | Apr 12, 2022 |
| 17765176 | LAMELLAR IRON SULFIDES WITH EMBEDDED CATIONS FOR ELECTRICAL ENERGY STORAGE | NGUYEN, KEVIN NMN | 1752 | §102§103 | Final Rejection | 73d overdue | Pending | Mar 30, 2022 |
| 17763445 | METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE AND THALASSEMIA | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Non-Final OA | 88d overdue | Pending | Mar 24, 2022 |
| 17763089 | METHOD OF CREATING ZERO-BURDEN DIGITAL BIOMARKERS FOR AUTISM, AND EXPLOITING CO-MORBIDITY PATTERNS TO DRIVE EARLY INTERVENTION | SANFORD, DIANA PATRICIA | 1687 | §101§112 | Final Rejection | — | Pending | Mar 23, 2022 |
| 17597793 | COMPOSITIONS AND METHODS COMPRISING PROTEASE-ACTIVATED THERAPEUTIC AGENTS | PETERS, ALEC JON | 1641 | §103§112Other | Non-Final OA | 16d | Pending | Jan 24, 2022 |
| 17596118 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH COLLAGEN BINDING DRUG CARRIERS | ALSOMAIRY, SARAH ABDOALATIF | 1646 | §103 | Final Rejection | 8d overdue | Pending | Dec 03, 2021 |
| 17595477 | COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES | OTTON, ALICIA L | 1699 | §102§112DP | Non-Final OA | — | Pending | Nov 17, 2021 |
| 17517084 | TREATMENT OF CANCER BY MANIPULATION OF COMMENSAL MICROFLORA | HINES, JANA A | 1645 | §103 | Final Rejection | — | Pending | Nov 02, 2021 |
| 17426583 | Bionic Breast | SISON, CHRISTINE ANDREA PAN | 3796 | §102§103 | Non-Final OA | — | Pending | Jul 28, 2021 |
| 17309936 | SYSTEMS AND METHODS FOR MODULATING RNA | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | §103 | Final Rejection | — | Pending | Jul 01, 2021 |
| 17311448 | COMPOSITIONS AND METHODS RELATED TO SITE-SPECIFIC IDENTIFICATION OF RNA MODIFICATIONS | VALLE, ERNESTO | 1623 | §103 | Non-Final OA | 79d | Pending | Jun 07, 2021 |
| 17337610 | METHODS AND COMPOSITIONS COMPRISING AN NFKB INHIBITOR AND AN ADJUVANT | BABSON, NICOLE PLOURDE | 1619 | §103 | Final Rejection | — | Pending | Jun 03, 2021 |
| 18236022 | BIOMARKERS OF RISK FOR INFECTION | GREENE, CAROLYN LEE | 1681 | §112 | Non-Final OA | 34d | Pending | Aug 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial